A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Clinical trial NCT03517488 · COMPLETED

Trial details

NCT number: NCT03517488
Sponsor: Xencor, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Breast Carcinoma Hepatocellular Carcinoma Urothelial Carcinoma Squamous Cell Carcinoma of the Head and Neck Renal Cell Carcinoma Colorectal Carcinoma Non-small Cell Lung Carcinoma Gastric or Gastroesophageal Junction Adenocarcinoma Endometrial Carcinoma Mesothelioma Neuroendocrine Carcinoma

Start date: 2018-07-10
Primary completion: 2022-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.